Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. HOMB
HOMB logo

HOMB Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Home BancShares Inc (HOMB) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
26.670
1 Day change
-0.71%
52 Week Range
30.830
Analysis Updated At
2026/04/17
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.
Sign Up

Home BancShares Inc (HOMB) is not a strong buy at the moment for a beginner investor with a long-term strategy and $50,000-$100,000 to invest. While the company has shown modest financial growth and completed an acquisition, the recent price decline, insider selling, and lack of strong proprietary trading signals suggest holding off for now.

Technical Analysis

The MACD is above 0 but positively contracting, indicating weakening momentum. RSI is neutral at 30.836, and moving averages are converging, showing no clear trend. The stock is near its key support level (S1: 26.663), but the overall technical indicators do not suggest a strong buy signal.

Options Data

Bullish
Open Interest Put-Call Ratio
Bearish
Option Volume Put-Call Ratio

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
9
Buy
2

Positive Catalysts

  • Q1 financials showed modest growth in revenue (3.98% YoY) and net income (2.60% YoY). EPS also increased by 3.45% YoY.

Neutral/Negative Catalysts

  • Insiders are selling heavily, with a 564.50% increase in selling activity over the last month. Revenue in Q1 fell short of expectations despite an EPS beat. The stock price has declined significantly in the regular market (-3.36%) and pre-market (-2.42%).

Financial Performance

In Q1 2026, Home BancShares reported revenue growth of 3.98% YoY to $246.49 million, net income growth of 2.60% YoY to $118.21 million, and EPS growth of 3.45% YoY to $0.60. However, revenue missed analyst expectations.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

Cantor Fitzgerald lowered the price target from $32 to $31 and maintained a Neutral rating. Analysts remain bullish for 2026 but acknowledge near-term uncertainty due to external factors like tariff concerns and market volatility.

Wall Street analysts forecast HOMB stock price to rise
6 Analyst Rating
Wall Street analysts forecast HOMB stock price to rise
2 Buy
4 Hold
0 Sell
Moderate Buy
Current: 26.860
sliders
Low
32
Averages
33
High
35
Current: 26.860
sliders
Low
32
Averages
33
High
35
Keefe Bruyette
Catherine Mealor
Market Perform
downgrade
$32 -> $30
AI Analysis
2026-04-20
New
Reason
Keefe Bruyette
Catherine Mealor
Price Target
$32 -> $30
AI Analysis
2026-04-20
New
downgrade
Market Perform
Reason
Keefe Bruyette analyst Catherine Mealor lowered the firm's price target on Home BancShares to $30 from $32 and keeps a Market Perform rating on the shares.
Stephens
Overweight
downgrade
$34 -> $32
2026-04-17
New
Reason
Stephens
Price Target
$34 -> $32
2026-04-17
New
downgrade
Overweight
Reason
Stephens lowered the firm's price target on Home BancShares to $32 from $34 and keeps an Overweight rating on the shares. Q1 results were slowed by disappointing loan yields, but the Q1 credit deterioration was driven by a single commercial credit, says the analyst, who doesn't think it was indicative of a broader trend.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for HOMB
Unlock Now

People Also Watch